Home › Cholesterol › Tennessee
Cholesterol clinical trials in Tennessee
3 studies for Cholesterol are looking for participants at sites in Tennessee.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Stern Cardiovascular Center, Germantown
- Ballad Health System, Greeneville
- Apex Research Foundation, LLC, Jackson
- and 2 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Knoxville
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- University of Tennessee Medical Center, Knoxville
- University of Tennessee Health Science Center/Regional One Health, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Jan 29, 2026 · NCT06374277From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.